CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Nevakar, LLC

For profitWebsite ↗

Also known as: NEVAKAR | Nevakar, Inc | Nevakar, Inc. | NEVAKAR INJECTABLES | Nevakar Injectables, Inc. | Nevakar, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Jun 27, 2023

Timeline

2010s

Jun 1, 2015
Nevakar, LLC— Founded

2020s

Oct 16, 2020
ephedrine— Marketing Organization
Jun 27, 2023
cyclophosphamide— NDA Secondary Org

Drugs by trial phase (4 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

atropine

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (2)

Recent trials (10)

NCT04883996CollaboratorPhase 1/Phase 2Dec 1, 2020
NCT04495283Lead sponsorPhase 2Aug 31, 2020
NCT04495283CollaboratorPhase 2Aug 31, 2020
NCT04265456CollaboratorPhase 1Jan 14, 2020
NCT04018612Lead sponsorPhase 2Apr 25, 2019
NCT04018612Study directorPhase 2Apr 25, 2019
NCT03652818Lead sponsorPhase 2Jun 28, 2018
NCT03652818Study directorPhase 2Jun 28, 2018
NCT03350620Study directorPhase 3Nov 20, 2017
NCT03350620Lead sponsorPhase 3Nov 20, 2017

Details

Founded: Bridgewater, NJ, US Jun 1, 2015
Last known activity: Jun 27, 2023